CLDN3 and colitis: After treatment with SC-5, the expression levels of occludin, claudin-3, and ZO-1 were up-regulated compared with the DSS group (p < 0.05), indicating that SC-5 can alleviate DSS-induced colitis in mice by enhancing the expression of tight junction proteins.